Browse grants

Food and Drug Administration · Up to $250K

An FDA R01 funding safety and effectiveness testing to support approval of drugs for minor uses or minor species (MUMS) in veterinary medicine. Eligibility is limited to entities developing such drugs (or their research partners) that already hold an INAD file and a MUMS designation from FDA/CVM, with a protocol pre-reviewed by FDA, so this requires existing regulatory standing with FDA. Awards reach up to about $250,000. Not a fit unless the applicant is already in the FDA veterinary drug development pipeline.

Food and Drug Administration · Up to $200K

This FDA cooperative agreement funds state and academic partners to strengthen antibiotic-resistance surveillance in retail food specimens as part of the NARMS program. Eligibility is broad, spanning universities, nonprofits (with or without 501(c)(3) status), small and large businesses, and state, local, and tribal governments. Awards range up to $200,000.

Food and Drug Administration · Up to $300K

This FDA cooperative agreement funds state animal food safety programs working toward or maintaining full implementation of national inspection standards, with optional add-ons for mutual-reliance partnerships. It's restricted to state programs that already hold an active FDA inspectional contract and a valid prior agreement — a narrow, technical bar that rules out most nonprofits and businesses. Awards go up to $300,000 depending on funding track and tier.

Food and Drug Administration · Up to $1.5M

An FDA cooperative agreement (Laboratory Flexible Funding Model) to strengthen state human and animal food testing laboratories through sample testing, food-defense preparedness, and method development. Eligibility is narrow: applicants must be ISO 17025 accredited (or have an equivalent quality system) and, for most tracks, hold a valid 20.88 agreement with FDA before applying. Awards run up to about $1.5 million. This is largely limited to established state food-testing laboratories that already meet the accreditation and FDA-agreement requirements.

Food and Drug Administration · Up to $600K

This FDA award (up to $600,000) funds natural history studies that generate high-quality data to support medical product development for rare diseases with unmet needs. Eligibility is very broad, covering universities, nonprofits (with or without 501(c)(3) status), small and other for-profit businesses, tribal and local/state governments, and even foreign organizations and their non-U.S. components. No unusual disqualifiers are noted, and the deadline is not imminent.

Food and Drug Administration · Up to $1.3M

Open to public and private higher-education institutions, including HBCUs, tribal colleges, and other minority-serving institutions. This FDA U18 forms long-term academic partnerships to research avian influenza and emerging zoonotic threats, intentional genomic alterations in animals, and products for minor and veterinary species. Awards up to about $1,250,000.

Food and Drug Administration · Up to $900K

Open to nearly any organization — universities, nonprofits (with or without 501(c)(3)), for-profits and small businesses, state/local/tribal governments, and foreign organizations. This FDA R01 funds clinical trials of orphan products evaluating safety and efficacy to address unmet needs in rare diseases. Awards up to about $900,000; clinical trials are required.

Food and Drug Administration · $225K–$2.5M

This FDA grant (U18, $225,000 to $2,500,000) funds veterinary diagnostic laboratories in the Vet-LIRN network to build capacity for animal food safety and antimicrobial resistance testing, including equipment and method development. Eligibility is broad, covering nonprofits (with or without 501(c)(3) status), small businesses, for-profit organizations, universities, tribal governments, and state/local governments. No unusual disqualifiers are noted, and the deadline is not imminent.